Discuss This Drug

potassium citrate monohydrate

CHEBI:CHEBI_64746

Definition

A hydrate that is the monohydrate form of potassium citrate.

Chemical Information

Molecular Formula
C6H7K3O8
Molecular Mass
324.40990
Charge
0
SMILES
O.[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
InChI
InChI=1S/C6H8O7.3K.H2O/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;;1H2/q;3*+1;/p-3
InChIKey
PJAHUDTUZRZBKM-UHFFFAOYSA-K

Alternative Names

  • potassium citrate
  • potassium citrate.H2O
  • tripotassium 2-hydroxypropane-1,2,3-tricarboxylate--water (1/1)
  • tripotassium citrate monohydrate
  • Urocit-K

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

core#notation
CHEBI:64746
DRON_00010000
54993
oboInOwl#hasDbXref
Reaxys:3924344

Additional References

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

BFO_0000051
http://purl.obolibrary.org/obo/CHEBI_64733
core#notation
CHEBI:64746
pharm_class
Calcium Chelating Activity [MoA]
brand_name_suffix
EXTENDED RELEASE
active_ingredient_strength
5 meq/1
active_ingredient_name
POTASSIUM CITRATE
upc
0302450071112
spl_set_id
ff67f638-5b53-406a-962a-87773a91fc48
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
54993
oboInOwl#hasDbXref
Reaxys:3924344
oboInOwl#id
CHEBI:64746
generic_name
POTASSIUM CITRATE
product_type
DRUG FOR FURTHER PROCESSING
marketing_category
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20241231
route
ORAL
dosage_form
TABLET, EXTENDED RELEASE
marketing_start_date
20060901
labeler_name
Camber Pharmaceuticals, Inc
brand_name
UROCIT-K
brand_name_base
UROCIT-K
application_number
ANDA209758
spl_id
e5f8949f-ddb5-66ed-e053-2995a90adf54
product_ndc
0245-0070
package_ndc
0245-0070-11
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_35498
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
rxcui
898517
manufacturer_name
Camber Pharmaceuticals, Inc
package_marketing_start_date
20060901
unii
EE90ONI6FF
package_description
100 TABLET in 1 BOTTLE (0245-0070-11)
has_treatment
http://purl.obolibrary.org/obo/DOID_12679
owl#annotatedSource
t269300
owl#someValuesFrom
t3951840